2 results
Approved WMOCompleted
To determine which bowel preparation product is superior in cleansing the colon and in patient satisfaction.
Approved WMORecruiting
The aim of this feasibility study is to validate pre-treatment [89Zr]-bevacizumab PET/CT as an imaging biomarker for prediction of treatment response to bevacizumab treatment in patients with NF2 related (vestibular) schwannomas.